A 49-year-old man presents to the PMHNP for his regular medication management appointment. He has schizophrenia and has been treated with thioridazine (Mellaril) for the past 15 years. The PMHNP decides to switch this patient to a different antipsychotic due to which serious long-term consequence of high-dose thioridazine?

Choice A reason: Hyperprolactinemia is a known side effect of many antipsychotics, especially those that block dopamine D2 receptors in the tuberoinfundibular pathway. However, thioridazine is not particularly associated with this effect as a long-term consequence requiring discontinuation. Choice B reason: Priapism is a rare but serious side effect of some psychotropic medications, particularly those with alpha-adrenergic blocking properties. Thioridazine has minimal association with priapism and it is not a common reason for long-term discontinuation. Choice C reason: Tardive dyskinesia is a well-known risk of long-term use of typical antipsychotics, including thioridazine. However, while significant, it is not the most specific or unique reason for discontinuing thioridazine in this case. The question emphasizes a serious long-term consequence that is more distinctive to thioridazine. Choice D reason: Retinal pigmentation and retinal toxicity are serious long-term consequences of high-dose thioridazine, especially when doses exceed 800 mg/day. This can lead to irreversible visual impairment, including nyctalopia, blurred vision, and pigmentary changes in the retina. This rare but severe adverse effect is a key reason clinicians discontinue thioridazine in favor of safer alternatives.